Matthew Lang is General Counsel & Corp. Secy. of Myovant Sciences Ltd.. Currently has a direct ownership of 0 shares of MYOV, which is worth approximately $0. The most recent transaction as insider was on Mar 10, 2023, when has been sold 354,303 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Matthew Lang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2023
SELL
Sale (or disposition) back to the issuer
-
354,303 Reduced 100.0%
0 Common Shares
Jan 18 2023
SELL
Open market or private sale
$34,204 $26.89 p/Share
1,272 Reduced 0.36%
354,303 Common Shares
Jan 04 2023
SELL
Open market or private sale
$74,755 $26.9 p/Share
2,779 Reduced 0.78%
355,575 Common Shares
Oct 18 2022
SELL
Open market or private sale
$48,712 $25.2 p/Share
1,933 Reduced 0.54%
358,354 Common Shares
Oct 04 2022
SELL
Open market or private sale
$89,768 $24.4 p/Share
3,679 Reduced 1.01%
360,287 Common Shares
Aug 15 2022
SELL
Open market or private sale
$569,031 $18.23 p/Share
31,214 Reduced 7.9%
363,966 Common Shares
Aug 12 2022
BUY
Grant, award, or other acquisition
-
124,780 Added 24.0%
395,180 Common Shares
Jul 18 2022
SELL
Open market or private sale
$24,903 $12.87 p/Share
1,935 Reduced 0.71%
270,400 Common Shares
Jul 06 2022
SELL
Open market or private sale
$49,607 $13.4 p/Share
3,702 Reduced 1.34%
272,335 Common Shares
Apr 19 2022
SELL
Open market or private sale
$83,621 $10.45 p/Share
8,002 Reduced 2.82%
276,037 Common Shares
Apr 15 2022
BUY
Grant, award, or other acquisition
-
111,111 Added 28.12%
284,039 Common Shares
Apr 05 2022
SELL
Open market or private sale
$33,568 $13.78 p/Share
2,436 Reduced 1.39%
172,928 Common Shares
Jan 04 2022
SELL
Open market or private sale
$72,808 $16.27 p/Share
4,475 Reduced 2.49%
175,364 Common Shares
Oct 05 2021
SELL
Open market or private sale
$144,227 $21.62 p/Share
6,671 Reduced 3.58%
179,839 Common Shares
Jul 09 2021
SELL
Open market or private sale
$149,650 $21.52 p/Share
6,954 Reduced 3.59%
186,510 Common Shares
Apr 15 2021
BUY
Grant, award, or other acquisition
-
58,461 Added 23.21%
193,464 Common Shares
Apr 06 2021
SELL
Open market or private sale
$202,250 $18.62 p/Share
10,862 Reduced 7.45%
135,003 Common Shares
Mar 15 2021
SELL
Open market or private sale
$752,100 $25.07 p/Share
30,000 Reduced 17.06%
145,865 Common Shares
Mar 15 2021
BUY
Exercise of conversion of derivative security
$233,400 $7.78 p/Share
30,000 Added 14.57%
175,865 Common Shares
Dec 18 2020
SELL
Open market or private sale
$258,100 $25.81 p/Share
10,000 Reduced 6.42%
145,865 Common Shares
Dec 18 2020
BUY
Exercise of conversion of derivative security
$77,800 $7.78 p/Share
10,000 Added 6.03%
155,865 Common Shares
Dec 10 2020
SELL
Open market or private sale
$488,880 $25.2 p/Share
19,400 Reduced 11.74%
145,865 Common Shares
Dec 10 2020
BUY
Exercise of conversion of derivative security
$150,932 $7.78 p/Share
19,400 Added 10.51%
165,265 Common Shares
Dec 09 2020
SELL
Open market or private sale
$15,048 $25.08 p/Share
600 Reduced 0.41%
145,865 Common Shares
Dec 09 2020
BUY
Exercise of conversion of derivative security
$4,668 $7.78 p/Share
600 Added 0.41%
146,465 Common Shares

Also insider at

LYEL
Lyell Immunopharma, Inc. Healthcare
ML

Matthew Lang

General Counsel & Corp. Secy.
Brisbane, CA

Track Institutional and Insider Activities on MYOV

Follow Myovant Sciences Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYOV shares.

Notify only if

Insider Trading

Get notified when an Myovant Sciences Ltd. insider buys or sells MYOV shares.

Notify only if

News

Receive news related to Myovant Sciences Ltd.

Track Activities on MYOV